Koyfin Home > Directory > Health Care > Rigel Pharmaceuticals > Cash and Short-Term Investments

Rigel Pharmaceuticals Cash and Short-Term Investments Chart (RIGL)

Rigel Pharmaceuticals annual/quarterly Cash and Short-Term Investments from 2010 to 2020.
  • Rigel Pharmaceuticals Cash and Short-Term Investments for the quarter ending June 06, 2020 was $92m a -16.20% decrease of -15m year over year
  • Rigel Pharmaceuticals Cash and Short-Term Investments for the last 12 months ending June 06, 2020 was $92m a -16.20% decrease of -15m year over year
  • Rigel Pharmaceuticals Annual Cash and Short-Term Investments for 2019 was $98m a -31.06% decrease of -30m from 2018
  • Rigel Pharmaceuticals Annual Cash and Short-Term Investments for 2018 was $129m a 9.95% increase of 13m from 2017
  • Rigel Pharmaceuticals Annual Cash and Short-Term Investments for 2017 was $116m a 35.41% increase of 41m from 2016
Other Balance Sheet Metrics:
  • Rigel Pharmaceuticals Total Assets for the quarter ending September 09, 2018 was $123m a 3.29% increase of 4m year over year
  • Rigel Pharmaceuticals Other Liabilities for the quarter ending December 12, 2018 was $1m a 91.46% increase of 1m year over year
  • Rigel Pharmaceuticals Total Equity for the quarter ending September 09, 2018 was $103m a 2.73% increase of 3m year over year
View Chart On Koyfin

Quarterly RIGL Cash and Short-Term Investments Data

06/2020$92m
03/2020$96m
12/2019$98m
09/2019$107m
06/2019$112m
03/2019$128m
12/2018$129m
09/2018$116m
06/2018$135m
03/2018$94m

Annual RIGL Cash and Short-Term Investments Data

2019$98m
2018$129m
2017$116m
2016$75m
2015$126m
2014$143m
2013$212m
2012$298m
2011$248m
2010$177m